Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant
Theranostics · 2025
DOI: 10.7150/thno.108471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Min Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Retinoblastoma, Liposomes, Hydrogels, Quercetin. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- Department of Ophthalmology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Zitieren
APA
Lin, M., Liu, X., Li, J., Zou, H., Wang, J., Yan, Z., Liu, Y., Lyu, Y., & Feng, N. (2025). Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant. Theranostics. https://doi.org/10.7150/thno.108471
Vancouver
Lin M, Liu X, Li J, Zou H, Wang J, Yan Z, et al. Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant. Theranostics. 2025. doi:10.7150/thno.108471
BibTeX
@article{Lin2025,
author = {Lin, Min and Liu, Xiumei and Li, Jing and Zou, Hong and Wang, Jie and Yan, Zi and Liu, Ying and Lyu, Yaqi and Feng, Nianping},
title = {Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.108471}
}
EUVIMED